Lucie Bartova Selected Research

Lucie Bartova Research Topics

Disease

14	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 11/2010
5	Anxiety Disorders (Anxiety Disorder) 03/2024 - 01/2017
5	Treatment-Resistant Depressive Disorder 07/2020 - 11/2015
4	Depressive Disorder (Melancholia) 10/2023 - 01/2017
4	Panic Disorder (Panic Attack) 12/2020 - 01/2017
3	Psychotic Disorders (Schizoaffective Disorder) 01/2023 - 01/2018
3	Hypertension (High Blood Pressure) 01/2022 - 01/2019
3	Social Phobia 12/2020 - 01/2017
3	Agoraphobia 12/2020 - 01/2017
3	Schizophrenia (Dementia Praecox) 01/2020 - 01/2017
2	Mental Disorders (Mental Disorder) 01/2023 - 01/2017
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2022 - 01/2017
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2018 - 03/2017
1	Hypersensitivity (Allergy) 01/2023
1	Delirium 01/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	COVID-19 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Anterograde Amnesia 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Weight Gain 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Pulmonary Embolism 10/2022
1	Ventricular Tachycardia 01/2022
1	Hallucinations (Hallucination) 01/2021
1	Movement Disorders (Movement Disorder) 01/2021
1	Sleep Deprivation 01/2021
1	Hypokinesia (Bradykinesia) 01/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2020
1	Seasonal Affective Disorder 01/2019
1	Personality Disorders (Personality Disorder) 01/2019
1	Hypothyroidism 01/2018
1	Phobic Disorders (Phobia) 01/2017
1	Bulimia Nervosa 01/2017
1	Disease Susceptibility (Diathesis) 11/2016
1	Postpartum Depression (Post-Natal Depression) 11/2016
1	Mood Disorders (Mood Disorder) 11/2010

Drug/Important Bio-Agent (IBA)

20	Antidepressive Agents (Antidepressants)IBA 01/2023 - 11/2010
10	Antipsychotic Agents (Antipsychotics)IBA 11/2022 - 01/2017
5	BenzodiazepinesIBA 01/2023 - 01/2017
5	Ketamine FDA LinkGeneric 01/2023 - 01/2017
4	lavender oilIBA 03/2024 - 01/2023
3	Pregabalin (Lyrica)FDA Link 01/2022 - 01/2017
3	EsketamineIBA 01/2020 - 11/2015
2	Aripiprazole (Abilify)FDA Link 01/2023 - 11/2022
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2021 - 01/2019
2	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2017
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2011
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 03/2011
1	Volatile Oils (Essential Oils)IBA 03/2024
1	Anti-Anxiety Agents (Anxiolytics)IBA 02/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2023
1	Clozapine (Clozaril)FDA LinkGeneric 01/2023
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2023
1	cariprazineIBA 01/2023
1	Zolpidem (Ambien)FDA LinkGeneric 01/2023
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2023
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	Quetiapine Fumarate (Seroquel)FDA Link 11/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2022
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021
1	naxagolideIBA 01/2020
1	Nasal SpraysIBA 01/2020
1	CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferaseIBA 01/2019
1	ChromatinIBA 01/2019
1	LithiumIBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Tuberculin (PPD)IBA 11/2016
1	Tranylcypromine (Parnate)FDA LinkGeneric 11/2015
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 11/2015
1	Monoamine Oxidase (MAO)IBA 11/2015

Therapy/Procedure

4	Therapeutics 01/2023 - 11/2010
2	Precision Medicine 01/2019 - 11/2010
2	Drug Therapy (Chemotherapy) 12/2018 - 01/2017
1	Catheters 10/2022
1	Phototherapy (Light Therapy) 01/2021